BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 4467175)

  • 41. [Minimal changes nephrotic syndrome associated to penicillamine treatment].
    Basterrechea MA; de Arriba G; García-Martín F; Sánchez-Heras M; Giménez-Vega E; Sánchez J
    Nefrologia; 2004; 24(2):183-7. PubMed ID: 15219094
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Massive breast enlargement in a patient receiving D-penicillamine for systemic sclerosis.
    Kahl LE; Medsger TA; Klein I
    J Rheumatol; 1985 Oct; 12(5):990-1. PubMed ID: 4087275
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A case of nodular scleroderma.
    Melani L; Caproni M; Cardinali C; Antiga E; Bernacchi E; Schincaglia E; Fabbri P
    J Dermatol; 2005 Dec; 32(12):1028-31. PubMed ID: 16471471
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Penicillamine for scleroderma.
    Fulghum DD; Katz R
    Arch Dermatol; 1968 Jul; 98(1):51-2. PubMed ID: 5241672
    [No Abstract]   [Full Text] [Related]  

  • 45. Nodular scleroderma: focally increased tenascin expression differing from that in the surrounding scleroderma skin.
    Mizutani H; Taniguchi H; Sakakura T; Shimizu M
    J Dermatol; 1995 Apr; 22(4):267-71. PubMed ID: 7541812
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Eosinophilic fasciitis--progression to linear scleroderma: a case report.
    Balat A; Akinci A; Turgut M; Mizrak B; Aydin A
    Turk J Pediatr; 1999; 41(3):381-5. PubMed ID: 10770102
    [TBL] [Abstract][Full Text] [Related]  

  • 47. In vitro inhibition of hematopoiesis in a patient with systemic sclerosis treated with D-penicillamine.
    Katayama Y; Kohriyama K; Matsui T
    J Rheumatol; 1999 Nov; 26(11):2493-5. PubMed ID: 10555917
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Goodpasture-like syndrome induced by D-penicillamine in a patient with systemic sclerosis: report and review of the literature.
    Derk CT; Jimenez SA
    J Rheumatol; 2003 Jul; 30(7):1616-20. PubMed ID: 12858467
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pemphigus vulgaris induced by D-penicillamine therapy in a patient with systemic sclerosis.
    Shapiro M; Jimenez S; Werth VP
    J Am Acad Dermatol; 2000 Feb; 42(2 Pt 1):297-9. PubMed ID: 10642693
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Penicillamine in the treatment of scleroderma. Lathyrogenic drugs].
    Szczepanski A
    Przegl Dermatol; 1971; 58(3):355-9. PubMed ID: 4944035
    [No Abstract]   [Full Text] [Related]  

  • 51. Combination therapies for systemic sclerosis.
    Denton CP; Black CM
    Springer Semin Immunopathol; 2001; 23(1-2):109-29. PubMed ID: 11455851
    [No Abstract]   [Full Text] [Related]  

  • 52. 65Zinc absorption in untreated and D-penicillamine-treated patients with generalized scleroderma: determination by whole-body counting technique.
    Høyer H; Hvid-Jacobsen K; Weismann K
    Acta Derm Venereol; 1982; 62(5):438-40. PubMed ID: 6183898
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Zinc and zinc-dependent enzymes in penicillamine-treated patients with generalized scleroderma.
    Jepsen LV; Eggert J
    Acta Derm Venereol; 1984; 64(5):424-7. PubMed ID: 6208723
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Immunological alterations during photopheresis and D-penicillamine treatment of systemic sclerosis.
    Rietschel RL; Cooper ES
    Ann N Y Acad Sci; 1991 Dec; 636():400-2. PubMed ID: 1793227
    [No Abstract]   [Full Text] [Related]  

  • 55. D-penicillamine treatment of lung involvement in patients with systemic sclerosis (scleroderma).
    Medsger TA
    Arthritis Rheum; 1987 Jul; 30(7):832-4. PubMed ID: 3304300
    [No Abstract]   [Full Text] [Related]  

  • 56. [D-Penicillamine effect on collagen synthesis and structural maintenance Red Sirius staining with polarized-light examination. The value of this staining in cases of collagen diseases (author's transl)].
    Pieraggi MT; Bonafe JL
    Ann Pathol; 1982; 2(2):155-7. PubMed ID: 6179525
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Does long-term treatment with D-penicillamine alter calcium and phosphorus metabolism in patients with systemic sclerosis?
    Hagdrup H; Serup J; Tvedegaard E
    Acta Derm Venereol; 1983; 63(5):447-9. PubMed ID: 6197850
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Systemic sclerosis].
    Gustafsson R
    Nord Med; 1994; 109(8-9):236-7. PubMed ID: 7937033
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effect of D-penicillamine on pulmonary fibrosis in patients with systemic sclerosis.
    Jinnin M; Ihn H; Asano Y; Yamane K; Yazawa N; Tamaki K
    Ann Rheum Dis; 2003 Oct; 62(10):1019-20. PubMed ID: 12972489
    [No Abstract]   [Full Text] [Related]  

  • 60. Treatment of systemic sclerosis with D-penicillamine. A new method of observing the effects of treatment.
    Bluestone R; Grahame R; Holloway V; Holt PJ
    Ann Rheum Dis; 1970 Mar; 29(2):153-8. PubMed ID: 5427411
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.